Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea

被引:37
|
作者
Carmona-Bernal, C
Quintana-Gallego, E
Villa-Gil, M
Sánchez-Armengol, A
Martínez-Martínez, A
Capote, F
机构
[1] Virgen Rocio Univ Hosp, Med Surg Unit Resp Dis, Seville, Spain
[2] Virgen Rocio Univ Hosp, Dept Cardiol, Seville, Spain
关键词
brain natriuretic peptide; central sleep apnea; Cheyne-Stokes respiration; congestive heart failure;
D O I
10.1378/chest.127.5.1667
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To assess the possible relationship between Cheyne-Stokes respiration (CSR) associated with central sleep apnea (CSA) syndrome and brain natriuretic peptide (BNP) in an outpatient population presenting with stable congestive heart failure (CHF). Measurements and results: Ninety patients with CHF due to systolic dysfunction (left ventricular ejection fraction <= 45%) were prospectively studied. Each patient underwent conventional polysomnography to establish the diagnosis of CSR-CSA and determination of the BNP level. The correlation between BNP levels and the apnea-hypopnea index (AHI) and desaturation index (DI) was evaluated, as was the accuracy of BNP in identifying CHF-associated CSR-CSA, as determined by the area under the receiver operating characteristic (ROC) curve. Possible confounding variables were assessed, and a stepwise multiple regression analysis was applied to identify those factors that best predicted the variability in BNP levels. Five of the 90 patients were excluded from the study as they presented with obstructive sleep apnea syndrome. Of the remaining 85 patients, 25 (28%) presented with associated CSR-CSA. The mean (+/- SEM) BNP level was higher in this group (166.44 +/- 29.6 pg/mL) than in the group with isolated CHF (62.01 +/- 13.6 pg/mL; p < 0.001). There was a moderate correlation between BNP levels and AHL The ROC curve that best identified CSR-CSA was obtained with a BNP cutoff value of 116.25 pg/mL (sensitivity, 62%; specificity, 92%; accuracy, 83%). Differences between the two groups in terms of BNP levels persisted after adjusting for the confounding variables that were analyzed. Only AHI and DI were independently, related to the BNP level, and both explain the 30.5% variability. Conclusion: Patients with CHF and CSR-CSA have higher BNP levels than those without CSR-CSA. Our results suggest that CSR-CSA and BNP levels are related. However, the possibility that both factors might be independent expressions of the functional status of CHF patients cannot be ruled out.
引用
收藏
页码:1667 / 1673
页数:7
相关论文
共 50 条
  • [21] Brain natriuretic peptide in the contemporary management of congestive heart failure
    Wasywich, Cara A.
    Whalley, Gillian A.
    Doughty, Robert N.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) : 71 - 84
  • [22] Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea
    Arzt, Michael
    Weinreich, Gerhard
    Oldenburg, Olaf
    Graml, Andrea
    Teschler, Helmut
    Wegscheider, Karl
    Erdmann, Erland
    Woehrle, Holger
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] Relation of Central Sleep Apnea to B-Type Natriuretic Peptide in Chronic Heart Failure
    Shima, A.
    Inami, T.
    Kitomi, N.
    Ikeda, T.
    Miyauchi, Y.
    Seino, Y.
    Shimizu, W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Sleep apnea in congestive heart failure
    Naughton, MT
    Bradley, TD
    [J]. CLINICS IN CHEST MEDICINE, 1998, 19 (01) : 99 - +
  • [25] Sleep apnea in congestive heart failure
    Brisco M.A.
    Goldberg L.R.
    [J]. Current Heart Failure Reports, 2010, 7 (4) : 175 - 184
  • [26] Efficacy of various treatment options in patients with central sleep apnea and congestive heart failure
    Dohi, T
    Narui, K
    Kasai, T
    Seko, T
    Fujimoto, Y
    Mitani, H
    Maehara, A
    Ishiwata, S
    Yamaguchi, T
    Momomura, SI
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S320 - S320
  • [27] DIFFERENT SECRETION PATTERNS OF ATRIAL-NATRIURETIC-PEPTIDE AND BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    YOSHIMURA, M
    YASUE, H
    OKUMURA, K
    OGAWA, H
    JOUGASAKI, M
    MUKOYAMA, M
    NAKAO, K
    IMURA, H
    [J]. CIRCULATION, 1993, 87 (02) : 464 - 469
  • [28] Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure
    MacDonald, KA
    Kittleson, MD
    Munro, C
    Kass, P
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2003, 17 (02) : 172 - 177
  • [29] Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea
    Zhao, ZH
    Liu, ZH
    Luo, Q
    Xiong, CM
    Ni, XH
    Zhang, J
    Zhang, S
    Yang, YJ
    [J]. CIRCULATION JOURNAL, 2006, 70 (05) : 572 - 574
  • [30] Nesiritide - A brain natriuretic peptide for acutely decompensated congestive heart failure
    Caron, MF
    White, CM
    [J]. FORMULARY, 2001, 36 (09) : 639 - 643